National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Antimicrobial (Drug) Resistance
 Understanding Antimicrobial (Drug) Resistance
 Research
 Examples of Antimicrobial Resistance
  MRSA
   Overview
   History
   Transmission
   Diagnosis
   Treatment
   Prevention
   Research
   MRSA in Labs and Locker Rooms
  VRE


Antimicrobial (Drug) Resistance

Methicillin-Resistant Staphylococcus aureus (MRSA)

Treatment

Healthcare providers can treat many S. aureus skin infections by draining the abscess or boil and may not need to use antibiotics. Draining of skin boils or abscesses should only be done by a healthcare provider.

For mild to moderate skin infections, incision and drainage by a healthcare provider is the first-line treatment. Before prescribing antibiotics, your provider will consider the potential for antibiotic resistance. Thus, if MRSA is suspected, your provider will avoid treating you with beta-lactam antibiotics, a class of antibiotic observed not to be effective in killing the staph bacteria.

For severe infection, doctors will typically use vancomycin intravenously.

previous link Diagnosis | Index | Prevention next link

Volunteer for Clinical Studies

Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.

Related Links

View a list of links for more information about antimicrobial (drug) resistance.

E-mail Icon E-mail this page
Print Icon Print this page

Volunteer for Clinical Studies

Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.

Related Links

View a list of links for more information about antimicrobial (drug) resistance.